An official website of the United States government
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Trial Status: active
The goal of this observational study is to collect information on the use of the
HistoSonics Edison System for the treatment of liver tumors. The main aim is to
understand how different patient characteristics and procedural characteristics may
affect histotripsy success at 36 hours post-histotripsy procedure. Sub-studies to the
BOOMBOX: Master Study will investigate specific populations and/or clinical questions
with more stringent enrollment criteria, standardized testing criteria, and/or follow-up
schedule. Any participant enrolled in the BOOMBOX: Master Study that also qualifies for a
sub-study may enroll in the sub-study in parallel; sub-studies will be described in
separate sub-study protocols. The BOOMBOX: Master Study will collect information about
participants before, during, and after the histotripsy treatment procedure. All
participants will be followed per standard clinical follow-up based on each site's
clinical practice for up to 5 years after the initial histotripsy procedure or until
completion of their follow-up in a sub-study, whichever is longer.
Inclusion Criteria
Subject is ≥22 years of age
Subject has signed the Ethics Committee (EC), or Institutional Review Board (IRB) approved study Informed Consent Form (ICF) prior to any study related tests/procedures and is willing to comply with study procedures and required follow-up assessments
Subject's liver tumor(s) can be partially or completely treated with histotripsy
Exclusion Criteria
Subject is pregnant or planning to become pregnant or nursing (lactating) during the study period
Subject is enrolled in an interventional HistoSonics-sponsored trial
Subject has a concurrent condition that, in the investigator's opinion, could jeopardize the safety of the subject or compliance with the protocol
Study sponsor and potential other locations can be found on ClinicalTrials.gov for NCT06486454.
Locations matching your search criteria
United States
Illinois
Chicago
University of Chicago Comprehensive Cancer Center
Status: Active
Name Not Available
Massachusetts
Boston
Brigham and Women's Hospital
Status: Active
Name Not Available
New York
New York
NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center
Status: Active
Name Not Available
Laura and Isaac Perlmutter Cancer Center at NYU Langone
Status: Active
Name Not Available
Ohio
Cleveland
Case Comprehensive Cancer Center
Status: Active
Name Not Available
Columbus
Ohio State University Comprehensive Cancer Center
Status: Approved
Name Not Available
Wisconsin
Madison
University of Wisconsin Carbone Cancer Center - University Hospital
Status: Active
Name Not Available
BOOMBOX: Master Study is an observational, single arm, non-randomized, prospective master
study. Following histotripsy treatment of liver tumor(s), subjects will undergo imaging
≤36 hours post-histotripsy treatment procedure to determine histotripsy success. Subjects
will then be followed per standard clinical follow-up as determined at each site with
regular review of adverse event data for up to 5 years or until completion of their
follow-up in a sub-study, whichever is longer.
As an observational study, the master protocol does not direct the use of the HistoSonics
Edison System towards any specific clinical intent or any specific disease state. Rather,
it will uniformly enroll patients and capture real-world standard-of-care data on the
usage of the HistoSonics Edison System as implemented by the treating physician on all
subjects treated with histotripsy that meet the study criteria and agree to participate
in the study. Sub-studies to the master protocol will investigate specific populations
and/or clinical questions with more stringent enrollment criteria, standardized testing
criteria, and/or follow-up schedule. Any subject enrolled in the master study who also
qualifies for a sub-study may enroll in the sub-study in parallel to the master study.
